The mining of rare diseases | Pharma’s Windfall | The Seattle Times
Michael J. Berens, seattletimes.com

Thir­ty years ago, Con­gress acted to spur research on rare dis­eases. Today, we have hun­dreds of new drugs — along with run­away pric­ing and mar­ket manip­u­la­tion, as drug­mak­ers turn a law with …

A SEATTLE TIMES INVESTIGATION
PHARMA’S WINDFALL
The mining of rare disease @myhealthshare

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s